Active Ingredient(s):Ponesimod FDA Approved: * March 18, 2021 Pharm Company: *JANSSEN PHARMS Category:Multiple Sclerosis
Ponesimod, sold under the brand name Ponvory, is a medication for the treatment of multiple sclerosis (MS).
The most common side effects include upper respiratory tract infection, hepatic transaminase elevation, and hypertension.
Ponesimod was approved for medical use in the United States in March 2021 and in the European Union in June 2021.
* May have multiple approval dates, manufacturers, or labelers.